CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?

2.50
Hdl Handle:
http://hdl.handle.net/10547/224525
Title:
CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?
Authors:
Lee, Cindy; Guinn, Barbara-Ann; Brooks, Suzanne E.; Richardson, Deborah; Orchard, Kim
Citation:
CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials? 2010, 149 (5):795-6 Br. J. Haematol.
Publisher:
Wiley
Journal:
British journal of haematology
Issue Date:
Jun-2010
URI:
http://hdl.handle.net/10547/224525
DOI:
10.1111/j.1365-2141.2010.08100.x
PubMed ID:
20230402
Additional Links:
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08100.x/abstract
Type:
Article
Language:
en
ISSN:
1365-2141
Sponsors:
Leukaemia and Lymphoma Research, Cancer Research U.K.
Appears in Collections:
Biomedicine and Nutrition Research Group

Full metadata record

DC FieldValue Language
dc.contributor.authorLee, Cindyen_GB
dc.contributor.authorGuinn, Barbara-Annen_GB
dc.contributor.authorBrooks, Suzanne E.en_GB
dc.contributor.authorRichardson, Deborahen_GB
dc.contributor.authorOrchard, Kimen_GB
dc.date.accessioned2012-05-18T08:52:25Z-
dc.date.available2012-05-18T08:52:25Z-
dc.date.issued2010-06-
dc.identifier.citationCD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials? 2010, 149 (5):795-6 Br. J. Haematol.en_GB
dc.identifier.issn1365-2141-
dc.identifier.pmid20230402-
dc.identifier.doi10.1111/j.1365-2141.2010.08100.x-
dc.identifier.urihttp://hdl.handle.net/10547/224525-
dc.description.sponsorshipLeukaemia and Lymphoma Research, Cancer Research U.K.en_GB
dc.language.isoenen
dc.publisherWileyen_GB
dc.relation.urlhttp://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08100.x/abstracten_GB
dc.rightsArchived with thanks to British journal of haematologyen_GB
dc.subjectCD66en_GB
dc.subjecttargetted radiotherapyen_GB
dc.subjectmultiple myelomaen_GB
dc.subject.meshAged-
dc.subject.meshAged, 80 and over-
dc.subject.meshAntigens, CD-
dc.subject.meshAntigens, Neoplasm-
dc.subject.meshCell Adhesion Molecules-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshMultiple Myeloma-
dc.subject.meshPlasma Cells-
dc.subject.meshRadioimmunotherapy-
dc.titleCD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?en
dc.typeArticleen
dc.identifier.journalBritish journal of haematologyen_GB

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in UOBREP are protected by copyright, with all rights reserved, unless otherwise indicated.